MoorthieSCameronLSagooGSBonhamJRBurtonH.Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases. J Inherit Metab Dis. 2014;37(6):889-898.
2.
FraserHGeppertJJohnsonR, et al. Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review. Orphanet J Rare Dis. 2019;14(1):258.
3.
BoutronAAcquavivaCVianey-SabanC, et al. Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency. Mol Genet Metab. 2011;103(4):341-348.
4.
UzunÖÜÇavdarlıBKaralökS. Mitochondrial trifunctional protein deficiency as a polyneuropathy etiology in childhood. Turk J Pediatr. 2021;63(6):1097-1102.
5.
PrasunPLoPiccoloMKGinevicI.Long-chain hydroxyacyl-CoA dehydrogenase deficiency / trifunctional protein deficiency. In: AdamMPMirzaaGMPagonRA, et al., eds. GeneReviews®. Seattle, WA: University of Washington; 2022:1993-2023.
6.
YamadaKTaketaniT.Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency. J Hum Genet. 2019;64:73-85.
7.
BoRYamadaKKobayashiH, et al. Clinical and molecular investigation of 14 Japanese patients with complete TFP deficiency: a comparison with Caucasian cases. J Hum Genet. 2017;62(9):809-814.
8.
MiklasJWRuohola-BakerH.Using mitochondrial trifunctional protein deficiency to understand maternal health. J Cell Signal. 2020;1(3):97-101.
9.
VishwanathVA.Fatty acid beta-oxidation disorders: a brief review. Ann Neurosci. 2016;23(1):51-55.
10.
WajnerMAmaralAU.Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies. Biosci Rep. 2016;36(1):e00281.
11.
YangJYuanDTanX, et al. Analysis of a family with mitochondrial trifunctional protein deficiency caused by HADHA gene mutations. Mol Med Rep. 2022;25(2):47.
12.
LiuZRDongHLMaYWuZY.Identification and functional characterization of mutations within HADHB associated with mitochondrial trifunctional protein deficiency. Mitochondrion. 2019;49:200-205.
13.
BarvinskaOOlkhovychNGorovenkoN.High prevalence of c.1528G>C rearrangement in patients with long chain 3-hydroxyacyl-CoA dehydrogenase deficiency from Ukraine. Cytol Genet. 2018;52(3):198-203.
14.
DieboldISchönUHorvathR, et al. HADHA and HADHB gene associated phenotypes—identification of rare variants in a patient cohort by next generation sequencing. Mol Cell Probes. 2019;44:14-20.
15.
SpiekerkoetterULindnerMSanterR, et al. Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis. 2009;32(4):498-505.
16.
DjouadiFHabarouFLe BachelierC, et al. Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate. J Inherit Metab Dis. 2016;39(1):47-58.
17.
SuyamaTShimuraMFushimiT, et al. Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency. Mol Genet Metab Rep. 2020;24:100610.
